3-(4-Bromo-butyl)-imidazolidine-2,4-dione | 64966-25-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: 3-(4-Bromo-butyl)-imidazolidine-2,4-dione
• 英文别名: 3-(4-Bromobutyl)imidazolidine-2,4-dione
• CAS: 64966-25-2
• 化学式: C₇H₁₁BrN₂O₂
• 分子量: 235.081
• InChiKey: FOOXWXNHSBKBTA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  49.4
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(4-Bromo-butyl)-imidazolidine-2,4-dione 、 (+)-4a,9b-trans-8-fluoro-5-(4-fluorophenyl)-1,2,3,4,4a,9b-hexahydro-γ-carboline 在 sodium carbonate 、 potassium iodide 作用下， 以 various solvent(s) 为溶剂， 以16%的产率得到3-{4-[(4aS,9bS)-8-Fluoro-5-(4-fluoro-phenyl)-1,3,4,4a,5,9b-hexahydro-pyrido[4,3-b]indol-2-yl]-butyl}-imidazolidine-2,4-dione
  参考文献：
  名称：

  Neuroleptic activity of chiral trans-hexahydro-.gamma.-carbolines

  摘要：

  A series of trans-8-fluoro-5-(4-fluorophenyl)-2,3,4,4a,5, 9b-hexahydro-1H-pyrido[4,3-b]indoles with various N-2 substituents has been prepared and tested for neuroleptic activity [( 3H]spiroperidol binding and amphetamine antagonism). Several members of this series showed exceptional in vivo potency, especially the hydantoin derivatives 27-30. Resolution into the enantiomers showed that neuroleptic activity is associated with the 4aS,9bS absolute configuration. These rigid neuroleptics have been correlated with other rigid neuroleptics [(+)-dexclamol, Ro 22-1319] and can serve to further define the topography of the dopamine receptor.

  DOI：

  10.1021/jm00151a002
• 作为产物：
  描述：

  1,4-二溴丁烷 、 potassium 2,5-dioxoimidazolidin-1-ide 以 N,N-二甲基甲酰胺 为溶剂， 反应 144.0h， 生成 3-(4-Bromo-butyl)-imidazolidine-2,4-dione
  参考文献：
  名称：

  Neuroleptic activity of chiral trans-hexahydro-.gamma.-carbolines

  摘要：

  A series of trans-8-fluoro-5-(4-fluorophenyl)-2,3,4,4a,5, 9b-hexahydro-1H-pyrido[4,3-b]indoles with various N-2 substituents has been prepared and tested for neuroleptic activity [( 3H]spiroperidol binding and amphetamine antagonism). Several members of this series showed exceptional in vivo potency, especially the hydantoin derivatives 27-30. Resolution into the enantiomers showed that neuroleptic activity is associated with the 4aS,9bS absolute configuration. These rigid neuroleptics have been correlated with other rigid neuroleptics [(+)-dexclamol, Ro 22-1319] and can serve to further define the topography of the dopamine receptor.

  DOI：

  10.1021/jm00151a002

文献信息

• Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
  申请人：PFIZER INC.

  公开号：EP0060610A1

  公开（公告）日：1982-09-22

  Derivatives of 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole and of (+)enantiomeric, mixtures of (+) and (-)-enantiomeric or (±)racemic 2,3,4,4a,5,9b-hexahydro-4a, 9b-trans-1H-pyrido[4,3-b]indole, substituted at the 5-position with an aryl group and at the 2-position with a carbonylaminoalkyl group or an aminoalkyl group, are neuroleptic agents useful in the treatment of certain psychoses and neuroses.

  2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚和(+)对映体的衍生物、(+)和(-)对映体的混合物或(±)外消旋2,3,4,4a,5,9b-六氢-4a,9b-反式-1H-吡啶并[4,3-b]吲哚的衍生物，在5位被芳基取代，在2位被羰基氨基烷基或氨基烷基取代，是治疗某些精神病和神经官能症的神经抑制剂。
• US4337250A
  申请人：——

  公开号：US4337250A

  公开（公告）日：1982-06-29
• US4427679A
  申请人：——

  公开号：US4427679A

  公开（公告）日：1984-01-24
• US4431646A
  申请人：——

  公开号：US4431646A

  公开（公告）日：1984-02-14
• US4431649A
  申请人：——

  公开号：US4431649A

  公开（公告）日：1984-02-14